Responsive image

Common name


tert-butyl N-methylcarbamate

IUPAC name


tert-butyl N-methylcarbamate

SMILES


O(C(=O)NC)C(C)(C)C

Common name


tert-butyl N-methylcarbamate

IUPAC name


tert-butyl N-methylcarbamate

SMILES


O(C(=O)NC)C(C)(C)C

INCHI


InChI=1S/C6H13NO2/c1-6(2,3)9-5(8)7-4/h1-4H3,(H,7,8)

FORMULA


C6H13NO2

Responsive image

Common name


tert-butyl N-methylcarbamate

IUPAC name


tert-butyl N-methylcarbamate





Molecular weight


131.173

clogP


0.081

clogS


-1.182

Frequency


0.0003





HBond Acceptor


2

HBond Donor


1

Total Polar
Surface Area


38.33

Number of Rings


0

Rotatable Bond


2

Drug ID Common name Structure CAS Compound class Therapeutic area
FDBD01092 Docetaxel Responsive image Antineoplastic Agents; Immunosuppressive Agents; Tubulin Modulators; Antineoplastic and Immunomodulating Agents; Taxanes; CYP3A4 Inhibitors; For the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. Also used as a single agent in the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy. It is also used in combination with prednisone, in the treatment of patients with androgen independent (hormone refractory) metastatic prostate cancer. Furthermore, docetaxel has uses in the treatment of gastric adenocarinoma and head and neck cancer.
1 , 1
FRAGNAME PDBID SIMILIRITY XSCORE SMILE HAC
1zsr_ligand_2_0.mol2 1zsr 1 -6.54 CNC(=O)OC(C)(C)C 9
1zsf_ligand_2_0.mol2 1zsf 1 -6.53 CNC(=O)OC(C)(C)C 9
1m0b_ligand_2_0.mol2 1m0b 1 -6.51 O=C(OC(C)(C)C)NC 9
1lzq_ligand_2_0.mol2 1lzq 1 -6.50 O=C(OC(C)(C)C)NC 9
1iiq_ligand_2_0.mol2 1iiq 1 -6.47 O=C(OC(C)(C)C)NC 9
1b6m_ligand_2_0.mol2 1b6m 1 -6.45 CNC(=O)OC(C)(C)C 9
1izh_ligand_2_168.mol2 1izh 1 -6.45 N(C(=O)OC(C)(C)C)C 9
1izi_ligand_2_168.mol2 1izi 1 -6.44 CNC(=O)OC(C)(C)C 9
4zls_ligand_2_71.mol2 4zls 1 -6.43 C(C)(C)(C)OC(=O)NC 9
101 , 11